Acquisition and Other Expense

6 Months Ended

Jun. 30, 2022

Acquisition and Other Expense [Abstract]

Acquisition and other expense consists of the following:


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021







Acquisition costs included in cost of sales	$	349	$	—	$	349	$	—


Acquisition costs	$	2,600	$	—	$	2,600	$	—

Legal matters	775		—		775		—
Restructuring and related costs	—		—		—		414

Acquisition and other costs included in selling and administrative expense	$	3,375	$	—	$	3,375	$	414





Convertible notes premium on extinguishment	$	103,125	$	—	$	103,125	$	—
Change in fair value of convertible notes hedges upon settlement	5,460		—		5,460		—
Loss on early extinguishment of debt	3,426		—		3,426		—
Debt related costs included in other expense	$	112,011	$	—	$	112,011	$	—

During the three and six months ended June 30, 2022 we recognized $0.3 million in costs for inventory step-up adjustments associated with the In2Bones Acquisition, as further described in Note 4.

During the three and six months ended June 30, 2022 we recognized $2.6 million in consulting and legal related fees associated with the acquisition of In2Bones, as further described in Note 4. These costs were included in selling and administrative expense.

During the three and six months ended June 30, 2022, we recognized $0.8 million in costs related to the settlement of litigation . These costs were included in selling and administrative expense.

During the six months ended June 30, 2021 we recorded a charge of $0.4 million related to the restructuring of our sales force which consisted primarily of termination payments to Orthopedic distributors made in exchange for ongoing

assistance to transition to employee-based sales representatives and severance. These costs were charged to selling and administrative expense.

During the three and six months ended June 30, 2022, we recorded expense of $103.1 million related to the conversion premium on the repurchase and extinguishment of $275.0 million of the 2.625% Notes, $5.5 million related to the settlement of the associated convertible notes hedge transactions and $3.4 million related to the write-off of deferred financing fees associated with the repurchase and extinguishment of $275.0 million of the 2.625% Notes and the pay down of $90.0 million on our term loan. These costs were recorded in other expense as further discussed in Note 11.